Transgene
Illkirch-graffenstaden · Founded 1979
About Transgene
Transgene is an integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Their expertise covers all stages of product development, from research to the manufacture of clinical batches, and the conducting of clinical trials.
Company Facts
- Founded: 1979
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $1K – $10K
- Total funding: $217.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: epa:TNG
- Website: transgene.fr
- Phone: + 33 (0) 3 88 27 91 00
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/transgene-69188 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.